Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2017-02-02 04:03 2017-01-30 PEN Penumbra Inc Elsesser Adam Director, Officer OPT+S $70.98 21,400 $1,518,991 1,235,838
2017-02-02 03:59 2017-01-30 PEN Penumbra Inc Rothman Lynn Officer SELL $70.99 4,414 $313,355 185,893
2017-02-02 03:57 2017-01-30 PEN Penumbra Inc Bose Arani Director, Officer OPT+S $70.97 21,400 $1,518,852 732,191
2017-02-02 03:55 2017-01-30 PEN Penumbra Inc Davis Daniel Donen Officer SELL $71.00 7,298 $518,144 51,049
2017-02-02 01:29 2017-01-17 OSUR ORASURE TECHNOLOGIES INC SPAIR RONALD H Director, Officer SELL $8.71 938 $8,171 163,213
2017-02-01 00:57 2017-01-27 REPR KORU Medical Systems, Inc. Manko Joseph M. Jr. Director, 10% owner BUY $0.43 7,700 $3,311 5,772,900
2017-01-31 18:42 2017-01-30 SYK STRYKER CORP FRANCESCONI LOUISE Director SELL $122.34 3,716 $454,623 16,642
2017-01-28 00:04 2017-01-25 REPR KORU Medical Systems, Inc. Manko Joseph M. Jr. Director, 10% owner BUY $0.41 15,000 $6,150 5,765,200
2017-01-28 04:31 2017-01-25 PEN Penumbra Inc Rothman Lynn Officer SELL $74.24 7,000 $519,688 190,307
2017-01-28 04:29 2017-01-25 PEN Penumbra Inc Davis Daniel Donen Officer SELL $74.25 10,970 $814,564 58,347
2017-01-28 04:26 2017-01-25 PEN Penumbra Inc Elsesser Adam Director, Officer OPT+S $74.13 31,500 $2,335,016 1,235,838
2017-01-28 04:24 2017-01-25 PEN Penumbra Inc Kassing Don W. Director SELL $74.50 3,000 $223,511 8,500
2017-01-28 04:22 2017-01-25 PEN Penumbra Inc Bose Arani Director, Officer OPT+S $74.12 31,500 $2,334,922 732,191
2017-01-26 04:49 2017-01-23 DXCM DEXCOM INC DOUBLEDAY RICHARD Officer SELL $79.50 3,182 $252,978 15,915
2017-01-26 04:49 2017-01-23 DXCM DEXCOM INC Pacelli Steven Robert Officer OPT+S $79.99 9,637 $770,908 110,409
2017-01-25 00:01 2017-01-20 REPR KORU Medical Systems, Inc. Manko Joseph M. Jr. Director, 10% owner BUY $0.42 45,000 $18,900 5,750,200
2017-01-24 01:33 2017-01-18 CMXC Stimcell Energetics Inc. JEFFS RICHARD 10% owner BUY $0.31 10,000 $3,100 2,360,432
2017-01-21 02:37 2017-01-18 DXCM DEXCOM INC ROPER JESS Officer SELL $85.01 3,012 $256,051 12,785
2017-01-20 00:26 2017-01-17 REPR KORU Medical Systems, Inc. Manko Joseph M. Jr. Director, 10% owner BUY $0.42 5,000 $2,100 5,705,200
2017-01-20 01:22 2017-01-17 RMD RESMED INC Hollingshead James Officer OPT+S $64.44 7,084 $456,493 39,670
2017-01-20 01:02 2017-01-17 OSUR ORASURE TECHNOLOGIES INC SPAIR RONALD H Director, Officer SELL $8.71 3,341 $29,103 160,810
2017-01-20 04:33 2017-01-17 DXCM DEXCOM INC SAYER KEVIN R Director, Officer OPT+S $85.94 10,000 $859,362 299,391
2017-01-18 22:27 2017-01-13 ADMD VIVOS INC Korenko Michael K Officer BUY $0.15 700,000 $105,000 717,500
2017-01-19 03:38 2017-01-13 DXCM DEXCOM INC LISTER JOHN Officer OPT+S $79.36 15,000 $1,190,400 70,598
2017-01-19 03:37 2017-01-13 DXCM DEXCOM INC VALDES JORGE A Officer OPT+S $80.00 26,100 $2,088,000 72,334
2017-01-14 01:04 2017-01-12 GKOS GLAUKOS Corp Calcaterra Chris M. Officer OPT+S $40.01 18,136 $725,552 240,000
2017-01-14 01:04 2017-01-12 GKOS GLAUKOS Corp HARRISON RICHARD L Officer OPT+S $40.00 20,634 $825,424 1,388
2017-01-14 00:39 2017-01-12 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $0.89 2,000,000 $1,780,000 12,065,642
2017-01-13 00:46 2017-01-10 CMXC Stimcell Energetics Inc. JEFFS RICHARD 10% owner BUY $0.30 10,000 $3,000 2,350,432
2017-01-13 03:21 2017-01-10 DXCM DEXCOM INC Balo Andrew K Officer OPT+S $62.86 3,200 $201,152 106,345
2017-01-12 00:31 2017-01-09 GKOS GLAUKOS Corp Burns Thomas William Director, Officer SELL $37.60 40,000 $1,504,000 260,240
2017-01-12 00:30 2017-01-09 GKOS GLAUKOS Corp Calcaterra Chris M. Officer OPT+S $38.02 20,000 $760,400 240,000
2017-01-12 03:33 2017-01-09 DXCM DEXCOM INC LISTER JOHN Officer OPT+S $63.02 3,000 $189,046 70,598
2017-01-12 03:31 2017-01-09 DXCM DEXCOM INC VALDES JORGE A Officer OPT+S $63.02 10,900 $686,905 72,334
2017-01-11 00:20 2017-01-06 REPR KORU Medical Systems, Inc. Manko Joseph M. Jr. Director, 10% owner BUY $0.43 22,500 $9,700 5,700,200
2017-01-11 00:08 2017-01-09 BSX BOSTON SCIENTIFIC CORP Pierce David A Officer SELL $22.24 10,232 $227,546 25,600
2017-01-11 00:06 2017-01-09 BSX BOSTON SCIENTIFIC CORP Pratt Timothy A. Officer SELL $22.24 6,195 $137,769 231,273
2017-01-10 00:00 2017-01-06 GKOS GLAUKOS Corp HARRISON RICHARD L Officer OPT+S $35.58 20,634 $734,143 1,388
2017-01-10 03:44 2017-01-03 CMXC Stimcell Energetics Inc. JEFFS RICHARD 10% owner BUY $0.28 58,500 $16,573 2,340,432
2017-01-05 21:00 2017-01-04 SYK STRYKER CORP Becker Yin C Officer OPT+S $120.22 11,660 $1,401,724 16,939
2017-01-06 01:24 2017-01-04 RMD RESMED INC FARRELL PETER C Director OPT+S $62.14 20,000 $1,242,760 301,557
2017-01-05 00:25 2016-12-29 REPR KORU Medical Systems, Inc. Manko Joseph M. Jr. Director, 10% owner BUY $0.47 321,821 $150,838 5,677,700
2017-01-05 00:01 2017-01-03 RMD RESMED INC PENDARVIS DAVID Officer OPT+S $61.95 6,365 $394,312 77,896
2016-12-30 21:03 2016-12-29 CMXC Stimcell Energetics Inc. JEFFS RICHARD 10% owner BUY $0.26 4,500 $1,185 2,281,932
2016-12-28 23:03 2016-12-28 SYK STRYKER CORP STRYKER RONDA E Director SELL $120.60 5,194 $626,410 7,789,916
2016-12-29 04:12 2016-12-23 DXCM DEXCOM INC DOUBLEDAY RICHARD Officer SELL $62.17 3,182 $197,831 19,097
2016-12-28 03:50 2016-12-22 SYK STRYKER CORP STRYKER RONDA E Director SELL $120.50 18,000 $2,168,951 7,795,110
2016-12-24 00:05 2016-12-21 TFX TELEFLEX INC GRAVES JEFFREY A Director OPT+S $160.57 5,000 $802,850 8,022
2016-12-23 22:25 2016-12-21 CMXC Stimcell Energetics Inc. JEFFS RICHARD 10% owner BUY $0.25 7,500 $1,900 2,277,432
2016-12-23 00:59 2016-12-21 NVCR NovoCure Ltd Ambrogi Michael J. Officer SELL $8.27 27,500 $227,304 131,584
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.